Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: Differences between normal controls and schizophrenic patients
- 1 April 1987
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 22 (4) , 479-494
- https://doi.org/10.1016/0006-3223(87)90170-3
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illnessJournal of Affective Disorders, 1986
- Positron Emission Tomography in Schizophrenic Patients with and without Neuroleptic MedicationJournal of Cerebral Blood Flow & Metabolism, 1985
- Alterations in regional brain concentrations of neurotensin and bombesin in Parkinson's diseaseAnnals of Neurology, 1985
- Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's diseaseAnnals of Neurology, 1984
- 15O POSITRON EMISSION TOMOGRAPHIC SCANNING IN PREDOMINANTLY NEVER-TREATED ACUTE SCHIZOPHRENIC PATIENTSThe Lancet, 1983
- Imaging Dopamine Receptors in the Human Brain by Positron TomographyScience, 1983
- Dopamine visualized in the basal ganglia of living manNature, 1983
- Selected Aspects of Amine and Receptor Hypotheses of Affective IllnessJournal of Clinical Psychopharmacology, 1981
- Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of methodAnnals of Neurology, 1979
- Central Catecholamine Neuron Systems: Anatomy and Physiology of the Dopamine SystemsAnnual Review of Neuroscience, 1978